Nancy Wysenski Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nancy Wysenski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nancy Wysenski. Nancy Wysenski is a EVP, Chief Commercial Officer in VERTEX PHARMACEUTICALS INC / MA ($VRTX).
Address: C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE 02139 MA
Companies in which Nancy Wysenski is an Insider
VERTEX PHARMACEUTICALS INC / MA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nancy Wysenski: EVP, Chief Commercial Officer
Holdings: 32,232 shares
Current Value: $2,799,027
Latest Transaction: May 16 2012
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Nancy Wysenski
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16 2012 | VRTX | VERTEX PHARMACEUTI ... | Wysenski Nancy | EVP, Chief Commerci ... | Option Exercise | M | 38.80 | 3,398 | 131,842 | 37,383 | |
| May 16 2012 | VRTX | VERTEX PHARMACEUTI ... | Wysenski Nancy | EVP, Chief Commerci ... | Option Exercise | M | 39.70 | 25,000 | 992,500 | 43,750 | |
| May 16 2012 | VRTX | VERTEX PHARMACEUTI ... | Wysenski Nancy | EVP, Chief Commerci ... | Option Exercise | M | 39.70 | 147,071 | 5,838,719 | 32,929 | |
| May 16 2012 | VRTX | VERTEX PHARMACEUTI ... | Wysenski Nancy | EVP, Chief Commerci ... | Option Exercise | M | 37.86 | 4,531 | 171,544 | 67,969 | |
| May 16 2012 | VRTX | VERTEX PHARMACEUTI ... | Wysenski Nancy | EVP, Chief Commerci ... | Sell | S | 65.00 | 372 | 24,180 | 32,232 | 32.6 K to 32.2 K (-1.14 %) |
| May 16 2012 | VRTX | VERTEX PHARMACEUTI ... | Wysenski Nancy | EVP, Chief Commerci ... | Sell | S | 64.27 | 179,628 | 11,544,692 | 32,604 | 212.2 K to 32.6 K (-84.64 %) |
| May 16 2012 | VRTX | VERTEX PHARMACEUTI ... | Wysenski Nancy | EVP, Chief Commerci ... | Buy | M | 38.80 | 3,398 | 131,842 | 212,232 | 208.8 K to 212.2 K (+1.63 %) |